retatrutide news News: Lilly is fighting the FDA in court in an attempt to have the triple agonist peptide classified as a biologic. We broke down the potential strategy of Lilly on today’s podcast. Retatrutide Shows 28% Weight Loss

The most common sites for B12 injections are the deltoid (upper arm), vastus lateralis (outer thigh), ventrogluteal (hip), abdomen, and outer upper arm for subcutaneous injections

[DOI] [PubMed] [Google Scholar] 3.Nassar M., Ghernautan V., Nso N., Nyabera A., Castillo F.C., Tu W., Medina L., Ciobanu C., Alfishawy M., Rizzo V., et al

Retrieved from Nguyen, H., Pellegrini, M

If you're already on a GLP-1 for diabetes or weight management and you're noticing endo improvements, document them and share with your doctor

Patients taking multiple cardiovascular medications require baseline assessment and periodic review

Even so, there are a few things to keep in mind